Tamiflu and Vesicare drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tamiflu (oseltamivir phosphate) and Vesicare (solifenacin succinate). Common drug interactions include osteoarthritis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Tamiflu and Vesicare. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Tamiflu?

Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.



On Aug, 11, 2026

43 people who take Tamiflu and Vesicare together, and have interactions are studied.

Tamiflu and Vesicare drug interactions.

What are the common drug interactions of Tamiflu and Vesicare, by gender? *:

female:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Peptic ulcer
  3. Platelet count increased
  4. Pneumonia fungal
  5. Post-traumatic pain
  6. Pruritus (severe itching of the skin)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Red blood cell count decreased
  9. Red cell distribution width increased
  10. Anxiety

male:

  1. Pneumonia
  2. Rash
  3. Blood creatinine increased
  4. Cardiac failure acute
  5. Chronic kidney disease
  6. Emotional distress
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Pain
  9. Renal failure acute (rapid kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Tamiflu and Vesicare, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))

30-39:

  1. Chronic kidney disease

40-49:

  1. Abdominal discomfort
  2. Pancreatitis (inflammation of pancreas)
  3. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Blood creatinine increased
  6. Blood potassium decreased
  7. Emotional distress
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Neuralgia (pain in one or more nerves)
  10. Pain

60+:

  1. Pneumonia
  2. Rash
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Chills (felling of cold)
  5. Hypertension (high blood pressure)
  6. Hypoxia (low oxygen in tissues)
  7. Acute hepatic failure
  8. Adverse reaction
  9. Ankle fracture
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 30.23%
  2. Multiple Myeloma (cancer of the plasma cells): 9 people, 20.93%
  3. High Blood Cholesterol: 6 people, 13.95%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.63%
  5. Pain: 4 people, 9.30%
  6. Depression: 4 people, 9.30%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 9.30%
  8. Blood Pressure Abnormal: 4 people, 9.30%
  9. Stress And Anxiety: 3 people, 6.98%
  10. Pneumonia: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Tamiflu and Vesicare?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tamiflu and Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tamiflu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamiflu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vesicare and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oseltamivir phosphate and solifenacin succinate (the active ingredients of Tamiflu and Vesicare, respectively), and Tamiflu and Vesicare (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: